Cheng Dezhi, Zhao Liang, Xu Yunsheng, Ou Rongying, Li Gang, Yang Han, Li Wenfeng
Laboratory for Interdisciplinary Research, Institution for Translational Medicine, The First Affiliated Hospital of Wenzhou Medical University, No. 2 of Fuxue Lane, Wenzhou City, Zhejiang Province, 325000, China.
Department of Thoracic Cardiovascular, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Tumour Biol. 2015 Sep;36(9):7221-32. doi: 10.1007/s13277-015-3429-8. Epub 2015 Apr 19.
Cigarette smoking might lead to lung cancer. However, the related signaling pathways at molecular level remained unknown until now. In this study, we studied the signaling processes associated between tobacco exposure and lung cancer. First, we detected and validated pathway-specific gene expression at bronchial epithelium. These proteins reflected the activation of signaling pathways relevant to tobacco exposure, including ATM, BCL2, GPX1, K-Ras, IKBKB, and SIRT1. Tobacco smoking was simulated via reactive oxygen species (ROS) pathway. ROS not only arrested cell cycle at G1/S stage but also increased expressions of Sirt1 and p27. Further studies showed that the expression of p27 was dependent on ERK1/2 activation, and p27 itself could halt cell cycle by inhibiting the activation of CDKs. Moreover, activation of K-Ras, the key regulator of Ras/ERK pathway, was tightly regulated by enzyme activity of Sirt1. Deacetylation of K-Ras by Sirt1 increased the transformation of Ras-GTP to Ras-GDP, promoting the activation of downstream of ERK1/2. In reverse, Ras/ERK pathway could also regulate Sirt1 transcription. In conclusion, inhibition of Sirt1 may be an effective strategy for the prevention of tumor progression in high-risk patients or as a therapeutic strategy in established tumors.
吸烟可能导致肺癌。然而,直到现在,分子水平上的相关信号通路仍不清楚。在本研究中,我们研究了烟草暴露与肺癌之间相关的信号传导过程。首先,我们检测并验证了支气管上皮细胞中特定信号通路的基因表达。这些蛋白质反映了与烟草暴露相关的信号通路的激活,包括ATM、BCL2、GPX1、K-Ras、IKBKB和SIRT1。通过活性氧(ROS)途径模拟吸烟。ROS不仅使细胞周期停滞在G1/S期,还增加了Sirt1和p27的表达。进一步研究表明,p27的表达依赖于ERK1/2的激活,并且p27自身可通过抑制CDKs的激活来使细胞周期停滞。此外,Ras/ERK途径的关键调节因子K-Ras的激活受到Sirt1酶活性的严格调控。Sirt1对K-Ras的去乙酰化增加了Ras-GTP向Ras-GDP的转化,促进了ERK1/2下游的激活。相反,Ras/ERK途径也可调节Sirt1的转录。总之,抑制Sirt1可能是预防高危患者肿瘤进展的有效策略,或作为已确诊肿瘤的治疗策略。